Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review

2021/10/01 by Adrian Pokorny, Adrian M. J. Pokorny, Alice Fabbri +5 · 6 citations
Pharmacology, Toxicology and Pharmaceutics · Economics, Econometrics and Finance · #Pharmaceutical industry and healthcare #Economic and Financial Impacts of Cancer #Healthcare Policy and Management

paper · doi:10.1038/s41416-021-01552-1

Citations

• Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?

Cited by

• A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland. [europepmc]
• Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. [europepmc]
• A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed? [europepmc]
• A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews. [europepmc]
• Increasing the focus on critical appraisal of trials and financial conflict of interest in medical training programs: a perspective from oncology. [europepmc]
• How often do oncologists receive industry payments from competing companies? [europepmc]